Cargando…
Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019
Renewed interest in developing vaccines against Neisseria gonorrhoeae has been sparked by the increasing threat of gonococcal antimicrobial resistance (AMR) and growing optimism that gonococcal vaccines are biologically feasible. Evidence suggests serogroup B Neisseria meningitidis vaccines might pr...
Autores principales: | Gottlieb, Sami L., Ndowa, Francis, Hook, Edward W., Deal, Carolyn, Bachmann, Laura, Abu-Raddad, Laith, Chen, Xiang-Sheng, Jerse, Ann, Low, Nicola, MacLennan, Calman A., Petousis-Harris, Helen, Seib, Kate L., Unemo, Magnus, Vincent, Leah, Giersing, Birgitte K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273195/ https://www.ncbi.nlm.nih.gov/pubmed/32359875 http://dx.doi.org/10.1016/j.vaccine.2020.02.073 |
Ejemplares similares
-
Critical Needs in Advancing Shigella Vaccines for Global Health
por: MacLennan, Calman A, et al.
Publicado: (2021) -
Progress Toward a Gonococcal Vaccine: The Way Forward
por: Russell, Michael W., et al.
Publicado: (2019) -
Experimental Gonococcal Infection in Male Volunteers: Cumulative Experience with Neisseria gonorrhoeae Strains FA1090 and MS11mkC
por: Hobbs, Marcia M., et al.
Publicado: (2011) -
The impact of antimicrobials on gonococcal evolution
por: Sánchez-Busó, Leonor, et al.
Publicado: (2019) -
Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations
por: Mvundura, Mercy, et al.
Publicado: (2021)